StreetInsider.com News Articles

Form 8-K Sintx Technologies, Inc. For: Oct 08

Fri, 09 Oct 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20261009/27172167.html

Form 8-K Sintx Technologies, Inc. For: Oct 01

Thu, 01 Oct 2026 09:05:00 -0400

si-local-file:///var/storage/secattach/20261001/27132794.html

SINTX Q3 revenue hits $2.2M, surpassing guidance on industrial sales

Thu, 01 Oct 2026 09:02:06 -0400

SINTX Technologies, Inc. (NASDAQ: SINT) reported preliminary, unaudited third-quarter revenue of $2.2 million for the period ended September 30, 2026, exceeding its previously issued guidance range of $0.9 million to $1.1 million.

The Salt Lake City-based company attributed the result primarily to industrial ceramics sales to aerospace subsidiaries of Fortune 500 companies. Revenue grew approximately 380% from the second quarter and was more than ten times the revenue reported in the same quarter of the prior year, according to the company's statement.

During the quarter, SINTX began shipments against more than $3.2 million in contract manufacturing purchase orders announced in June 2026.

SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance

Thu, 01 Oct 2026 09:00:00 -0400

Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance

Revenue milestone also enables Company to call Class B warrants

SALT LAKE CITY, Utah, Oct. 01, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced preliminary, unaudited revenue of $2.2 million* for the third quarter ended September 30, 2026. The result exceeds the high end of the Company’s previously

SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance

Thu, 01 Oct 2026 09:00:00 -0400

Third-quarter revenue grows roughly 380% from Q2, driven by stronger-than-expected industrial sales to Fortune 500 customers; Company reiterates Q4 revenue guidance

Revenue milestone also enables Company to call Class B warrants

SINTX Technologies sponsors silicon nitride masterclass for orthopedic pros

Mon, 14 Sep 2026 09:00:48 -0400

SINTX Technologies, Inc. (NASDAQ: SINT) announced the availability of a company-sponsored Masterclass hosted by Orthopedics This Week, examining silicon nitride as a material for orthopedic implant applications.

The Masterclass, titled "Silicon Nitride in Orthopedics," brings together three industry experts whose backgrounds span implant retrieval, biomaterials research, and clinical practice. The presentation covers the science behind medical-grade silicon nitride, clinical experience with the material, and how its surface chemistry and reported bone-cell response compare to established implant materials such as PEEK and titanium. The discussion also addresses potential future applications in composites and 3D printing.

The Salt Lake City-based company said the Masterclass

SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts

Mon, 14 Sep 2026 09:00:00 -0400

Experts in implant retrieval, biomaterials and clinical practice examine the science, clinical experience and potential advantages of silicon nitride relative to established implant materials in Company-sponsored Orthopedics This Week Masterclass

SALT LAKE CITY, Utah, Sept. 14, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company commercializing proprietary silicon nitride technologies across medical and other high-value applications, today announced the availability of a Company-sponsored Masterclass hosted by Orthopedics This Week (“OTW”), the most widely read publication in the orthopedics industry, that brings together

SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts

Mon, 14 Sep 2026 09:00:00 -0400

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Tue, 08 Sep 2026 08:00:00 -0400

SALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company commercializing proprietary silicon nitride technologies across medical and other high-value applications, today announced that it will participate in the 28th Annual H.C. Wainwright Global Investment Conference, taking place September 14–16, 2026, at the Lotte New York Palace Hotel in New York City.

Gregg Honigblum, Chief Investment Officer, and Ryan Elmore, President of SINTX, will deliver a company presentation and participate in one-on-one meetings with investors throughout the conference. The presentation

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Tue, 08 Sep 2026 08:00:00 -0400

Form EFFECT Sintx Technologies, Inc.

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946804.html

Form EFFECT Sintx Technologies, Inc.

Wed, 19 Aug 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260819/26946804.html

Form SCHEDULE 13G Sintx Technologies, Inc. Filed by: Bleichroeder LP

Thu, 13 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260813/26921317.html

Form SCHEDULE 13G Sintx Technologies, Inc. Filed by: Bleichroeder LP

Thu, 13 Aug 2026 16:16:00 -0400

si-local-file:///var/storage/secattach/20260813/26921317.html

Form 8-K Sintx Technologies, Inc. For: Aug 12

Thu, 13 Aug 2026 09:05:00 -0400

si-local-file:///var/storage/secattach/20260813/26917525.html

Form 8-K Sintx Technologies, Inc. For: Aug 12

Thu, 13 Aug 2026 09:05:00 -0400

si-local-file:///var/storage/secattach/20260813/26917525.html

Sintx Technologies regains Nasdaq stockholders' equity compliance

Thu, 13 Aug 2026 09:00:13 -0400

SINTX Technologies, Inc. (NASDAQ: SINT) announced it received written notification from Nasdaq confirming the company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain minimum stockholders' equity of $2.5 million.

The determination was based on SINTX's quarterly report on Form 10-Q for the quarter ended June 30, 2026, which reported stockholders' equity of approximately $4.83 million. Nasdaq confirmed that the previously disclosed deficiency matter is now closed.

"We are pleased to have resolved this matter and to have Nasdaq confirm our compliance with the minimum stockholders' equity requirement," said Eric K. Olson,

SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Thu, 13 Aug 2026 09:00:00 -0400

SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a company focused on advanced silicon nitride materials and medical technologies, today announced that it received written notification from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain minimum stockholders’ equity of $2.5 million.

Based on SINTX’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which

SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Thu, 13 Aug 2026 09:00:00 -0400

Based on SINTX’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which

SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Thu, 13 Aug 2026 09:00:00 -0400

Based on SINTX’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which

SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Thu, 13 Aug 2026 09:00:00 -0400

Based on SINTX’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026, which

H.C. Wainwright Reiterates Buy Rating on SINTX Tech (SINT)

Thu, 13 Aug 2026 06:57:56 -0400

H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating and $10.00 price target on SINTX Tech (NASDAQ: SINT).

The analyst commented: "Revenue of $0.45M was essentially in line with our $0.5M estimate and FactSet consensus, while EPS of $(0.56) was better than our $(0.81) estimate and FactSet at $(0.73). More importantly for the stock, SINT guided 3Q26 revenue to $0.9M-$1.1M versus FactSet at $0.7M and 4Q26 revenue to $1.0M-$1.3M, implying FY26 revenue of ~$2.7M-$3.2M versus our prior $1.9M estimate. The stronger outlook is largely supported by OEM/industrial demand rather than SiNAPTIC Foot & Ankle, however, we do view the industrial order

SINTX Technologies (SINT) files for 1.27M share offering by selling stockholders

Thu, 13 Aug 2026 06:04:31 -0400

SINTX Technologies (NASDAQ: SINT) filed for up to 1,268,135 share offering by selling stockholders.

SINTX Technologies (SINT) files for 1.27M share offering by selling stockholders

Thu, 13 Aug 2026 06:04:31 -0400

SINTX Technologies (NASDAQ: SINT) filed for up to 1,268,135 share offering by selling stockholders.

Form S-3 Sintx Technologies, Inc.

Thu, 13 Aug 2026 06:02:00 -0400

si-local-file:///var/storage/secattach/20260813/26915499.html